Contents


FOREWORD Tomorrow’s Virtual World—Big Pharma’s Big Chance


Sian Bithell Touch Briefings


REVIEW The Business of Virtualization in Research and Development


Sandy Johnston, Kate Moss, and Andy Brown PricewaterhouseCoopers


Empowering Virtualization, Enabling Next-generation Pharma


Nick Giannasi Oracle


Re-thinking Pharma R&D—The Merck Experience


Clark Golestani Merck & Co


Technology and People—Shifting the R&D Paradigm at GlaxoSmithKline


Alex Lancksweert, Peter Milligan, and Robin Dement GlaxoSmithKline


2 VIRTUALIZATION IN PHARMA R&D 16 13 9 4 3


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22